Measurement of tumor necrosis factor-α, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease

References

• AaronSDAngelJBLunauM2001Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1633495511179105
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyStandardization of spirometry – 1987 update. Statement of the American Thoracic SocietyAm Rev Respir Dis1361285983674589
   PubMedGoogle Scholar
• BaggioliniMWalzAKunkelSL1989Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophilsJ Clin Invest84104592677047
   PubMed Web of Science ®Google Scholar
• BarnesPJChowdhuryBKharitonovSA2006Pulmonary biomarkers in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med17461416556692
   PubMed Web of Science ®Google Scholar
• BhowmikASeemungalTASapsfordRJ2000Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax551142010639527
   PubMed Web of Science ®Google Scholar
• BiernackiWAKharitonovSABarnesPJ2003Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPDThorax58294812668789
   PubMed Web of Science ®Google Scholar
• BlandJMAltmanDG1986Statistical methods for assessing agreement between two methods of clinical measurementLancet1307102868172
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPW2000Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ320129730310807619
   PubMed Web of Science ®Google Scholar
• CarpagnanoGEKharitonovSAFoschino-BarbaroMP2003Increased inflammatory markers in the exhaled breath condensate of cigarette smokersEur Respir J215899312762340
   PubMed Web of Science ®Google Scholar
• CrooksSWBayleyDLHillSL2000Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4Eur Respir J152748010706491
   PubMed Web of Science ®Google Scholar
• DaviesLAngusRMCalverleyPM1999Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trialLancet3544566010465169
   PubMed Web of Science ®Google Scholar
• EffrosRMDunningMB3rdBillerJ2004The promise and perils of exhaled breath condensatesAm J Physiol Lung Cell Mol Physiol287L10738015531756
   PubMed Web of Science ®Google Scholar
• Ford-HutchinsonAWBrayMADoigMV1980Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature28626456250050
   PubMed Web of Science ®Google Scholar
• GareyKWNeuhauserMMRobbinsRA2004Markers of inflammation in exhaled breath condensate of young healthy smokersChest12522614718416
   PubMed Web of Science ®Google Scholar
• GerritsenWBAsinJZanenP2005Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patientsRespir Med99849015672854
   PubMed Web of Science ®Google Scholar
• GessnerCScheibeRWotzelM2005Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary diseaseRespir Med9912294016140223
   PubMed Web of Science ®Google Scholar
• HorvathIHuntJBarnesPJ2005Exhaled breath condensate: methodological recommendations and unresolved questionsEur Respir J265234816135737
   PubMed Web of Science ®Google Scholar
• HuntJ2002Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung diseaseJ Allergy Clin Immunol110283412110814
   PubMed Web of Science ®Google Scholar
• HurstJRDonaldsonGCPereraWR2006Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1748677416799074
   PubMed Web of Science ®Google Scholar
• IpMSKoFWLauAC2006Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilizationChest1293849216478856
   PubMed Web of Science ®Google Scholar
• KeatingsVMCollinsPDScottDM1996Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthmaAm J Respir Crit Care Med15353048564092
   PubMed Web of Science ®Google Scholar
• KeatingsVMJatakanonAWorsdellYM1997Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPDAm J Respir Crit Care Med15554289032192
   PubMed Web of Science ®Google Scholar
• KoFWIpMChanPK2007A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized With Acute Exacerbations of COPDChest131445217218555
   PubMed Web of Science ®Google Scholar
• KoFWLauCYLeungTF2006Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary diseaseRespir Med100630816213701
   PubMed Web of Science ®Google Scholar
• KoFWLauCYLeungTF2006Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patientsClin Exp Allergy36445116393265
   PubMed Web of Science ®Google Scholar
• KoFWLeungTFHuiDS2007Are exhaled breath condensates useful in monitoring asthma?Curr Allergy Asthma Rep7657117504663
   PubMed Web of Science ®Google Scholar
• LeungTFWongGWKoFW2005Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic childrenInt Arch Allergy Immunol137667215832052
   PubMed Web of Science ®Google Scholar
• LundbladLKThompson-FigueroaJLeclairT2005Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotypeAm J Respir Crit Care Med17113637015805183
   PubMed Web of Science ®Google Scholar
• MontuschiPBarnesPJ2002Analysis of exhaled breath condensate for monitoring airway inflammationTrends Pharmacol Sci23232712008001
   PubMed Web of Science ®Google Scholar
• MontuschiPKharitonovSACiabattoniG2003Exhaled leukotrienes and prostaglandins in COPDThorax58585812832671
   PubMed Web of Science ®Google Scholar
• MukhopadhyaySHoidalJRMukherjeeTK2006Role of TNFalpha in pulmonary pathophysiologyRespir Res712517034639
   PubMed Web of Science ®Google Scholar
• National Heart, Lung and Blood Institute, World Health OrganizationGlobal Initiative for chronic obstructive lung diseaseGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease Updated 2006NHLB/WHO2006
   Google Scholar
• OudijkEJGerritsenWBNijhuisEH2006Expression of priming-associated cellular markers on neutrophils during an exacerbation of COPDRespir Med1001791916531033
   PubMed Web of Science ®Google Scholar
• PatelISSeemungalTAWilksM2002Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbationsThorax577596412200518
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMLivnatGGirishM2007Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPDChest131374317218554
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEA1998Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1571418229603117
   PubMed Web of Science ®Google Scholar
• SmithADCowanJOBrassettKP2005Use of exhaled nitric oxide measurements to guide treatment in chronic asthmaN Engl J Med35221637315914548
   PubMed Web of Science ®Google Scholar
• Wood-BakerRRGibsonPGHannayM2005Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst RevCD00128815674875
   PubMed Web of Science ®Google Scholar
• YamamotoCYonedaTYoshikawaM1997Airway inflammation in COPD assessed by sputum levels of interleukin-8Chest112505109266891
   PubMed Web of Science ®Google Scholar